-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Globally, women and men (age greater than 25) have the same risk of experiencing a stroke in their lifetime, that is, a quarter
Stroke Another systematic review of patient-reported results showed that women experience more participation restrictions or barriers than men
prevention
However, instead of targeting precise gender equivalence, that is, 50% of men and women, participating in stroke trials should best reflect the gender-specific prevalence of stroke in the potential target population
Although research shows that women in heart blood vessels different representative experiment, but only to study the issue in stroke trials published until recently
Heart blood vessels
In this way, Cheryl Carcel and others of the University of New South Wales in Australia used a large database to investigate women’s participation in stroke trials based on the incidence of stroke
They identified randomized controlled trials published between 1990 and 2020 from the ClinicalTrials.
They found that 281 stroke trials were eligible for analysis, with a total of 588,887 participants, of which 37.
The biggest differences appeared in intracerebral hemorrhage trials (PPR 0.
Relative to the burden of disease in the population, the representation of women in stroke trials is too low
Relative to the burden of disease in the population, the representation of women in stroke trials is too low
Original Source:
Leave a message here
